Drospirenone + estetrol

Trade Name: 
Nextstellis
Manufacturer/Distributor: 
Searchlight Pharma Inc.
Classification: 
Oral contraceptive
ATC Class: 
G03AA18 - drospirenone + estetrol
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2021/03/21
Date Marketed in Canada (yyyy/mm/dd): 
2021/06/15
Presentation: 
Tablet: 15 mg estetrol + 3 mg drospirenone. DIN: 02513218
Comments: 
Combination product with estetrol and drospirenone. Contains 24 active tablets and 4 inert tablets.